TFFP - TFF Pharmaceuticals Inc. Kapitalizatsiyaning sotish hajmiga nisbati

TFF Pharma (TFFP) tovar belgisi

GURU.Markets vaqtlar ketma-ketligi grafigidagi TFF Pharmaceuticals (TFFP) kompaniyasining normallashtirilgan P/S ko'rsatkichi, bunda 22.30 qiymati joriy metrikaga mos keladi, sog'liqni saqlash gigantlaridan litsenziyalash royaltilari olish imkoniyatiga asoslangan. Biznes inhalatsiya uchun quruq kukunlar yaratishdagi innovatsiyalarga tayanib, texnologik to'siqni shakllantirmoqda. Biroq, geosiyosiy mojarolar va sanksiyalar komponentlarga kirishni cheklaydi va global sotuv bozorlarini toraytiradi.

TFF Pharmaceuticals, Inc (TFFP) - P/S multiplikatori 04.07.2022dan 24.09.2023gacha

TFF Pharma (TFFP) kompaniyasi koʻrsatkichlari kesimi va tahlili

- aksiya narxi va baholash bo'yicha konsensus prognoz:
Narxlar dinamikasi grafigi tffpharma.com|TFFP - Konsensus maqsadli narx
- bozor kapitallashuvi statistikasi:
Bozor qiymati TFF Pharma|TFFP - Korxona qiymati
- balans kapitallashuvi haqida ma'lumot:
Aksiyaning balans qiymati TFF Pharmaceuticals|TFFP - Balans kapitallashuvi|Sof aktivlarga nisbatan bozor kapitallashuvi tffpharma.com|TFFP - Kompaniyaning yakuniy aktivlari
- qarz majburiyatlari va likvidlik statistikasi:
Barcha qarzlarning o‘z mablag‘lariga nisbati TFF Pharmaceuticals|TFFP - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli majburiyatlarning o'z kapitaliga nisbati TFF Pharmaceuticals, Inc|TFFP - Kompaniyaning jamlangan qarzlari|Qarzning sof aktivlarga nisbati TFF Pharma|TFFP - Kompaniyaning uzoq muddatli qarzlari|Kompaniyaning qisqa muddatli qarzlari TFF Pharmaceuticals|Oraliq qoplash koeffitsiyenti tffpharma.com
- foyda va baholash multiplikatorlari ko'rsatkichlari:
TFFP - Kompaniyaning sof foydasi|Kelajakdagi foyda TFF Pharmaceuticals|TFFP - P/E multiplikatori|Forvard P/E multiplikatori TFF Pharmaceuticals Inc.|TFFP - PEG multiplikatori|Korxona qiymatining foizlar, soliqlar va amortizatsiyadan oldingi foydaga nisbati koeffitsiyenti TFF Pharma|TFFP - EBITDA operatsion foydasi|So'nggi o'n ikki oy davomida bitta aksiya uchun sof foyda TFF Pharmaceuticals|TFFP - So'nggi 12 oy davomida bir aksiya uchun sof foyda|Choraklik EPS foyda o'sishi tffpharma.com|TFFP - Bu yil bir aksiya uchun sof foyda o'sishi|Keyingi yilda bir aksiya uchun foydaning prognoz qilingan ortishi TFF Pharmaceuticals
- emitentning tushumi va sotuvlari tafsilotlari:
TFFP - Daromad va sotish hajmi|Kompaniyaning kelajakdagi savdosi tffpharma.com|TFFP - P/S multiplikatori|Forvard narx/daromad multiplikatori TFF Pharma
Kompaniyaning umumiy tahlili:tffpharma.com, TFFP
TFF Pharmaceuticals Inc. tayyor mahsulotlari

P/S koeffitsiyenti biznesning bozor qiymatini uning yillik savdo hajmi bilan nisbatda belgilaydi va investorlarning daromadning har bir birligi uchun to'lashga tayyor bo'lgan premiumini o'lchaydi. TFF Pharmaceuticals (TFFP) kompaniyasining P/S koeffitsiyenti dinamikasini tahlil qilish aktivlarning likvidatsiyasi va operatsiyalarning to'xtatilishi tufayli fundamental qiymatning yo'qolishi ushbu metrikani sof spekulyativ emrash ko'rsatkichiga qanday aylantirishini ochib beradi.

Raqobatdosh kompaniyalar

HLN (haleon.com) - Bozor kapitallashuvining daromadga nisbati|Kenvue - Kapitalizatsiyaning daromadga nisbati|Kapitalizatsiyaning sotish hajmiga nisbati VRNA (Verona Pharma PLC)|Jyong Biotech Corp - P/S multiplikatori|Narxning sotuvga nisbati LGND|AMRX: P/S multiplikatori|Narxning sotuvga nisbati PRGO (perrigo.com)|Kapitalizatsiyaning daromadga nisbati ALVO|LQDA: Bozor kapitallashuvining daromadga nisbati|Narxning daromadga nisbati Galapagos Genomics (GLPG)|ANIP: Narxning sotuvga nisbati|P/S multiplikatori MNKD (MannKind Corporation)|Bozor kapitallashuvining daromadga nisbati AMPH|Pacira BioSciences, Inc. - P/S multiplikatori|SPRY - P/S multiplikatori|Theravance (TBPH) - Narxning daromadga nisbati|Aquestive Corp - Bozor kapitallashuvining daromadga nisbati|Narxning daromadga nisbati scPharmaceuticals, Inc.|Kapitalizatsiyaning daromadga nisbati Tectonic (TECX)|P/S multiplikatori TNXP|P/S multiplikatori sxtchina.com (SXTC)|P/S multiplikatori EPRX (Eupraxia Pharmaceuticals Inc.)|BHST - Kapitalizatsiyaning daromadga nisbati|eXoZymes Inc - P/S multiplikatori|Sotuvga nisbatan narx Oramed Pharmaceuticals|ENTX (enterabio.com) - Kapitalizatsiyaning daromadga nisbati|MindWalk Holdings, Inc. (HYFT) - P/S multiplikatori|Kapitalizatsiyaning daromadga nisbati ABVC|CPIX (Cumberland Corp) - Kapitalizatsiyaning sotish hajmiga nisbati|P/S multiplikatori QNTM|Narx/daromad koeffitsiyenti fibrogen.com|P/S multiplikatori TELO (Telomir Pharmaceuticals, Inc.)|RANI - Kapitalizatsiyaning daromadga nisbati|Synergy CHC Corporation - P/S multiplikatori|RLYB - P/S multiplikatori|lexariabioscience.com (LEXX) - Narxning daromadga nisbati|PULM (pulmatrix.com) - Narxning daromadga nisbati|Narxning daromadga nisbati Pheton Holdings Limited|Aptorum (APM) - Narx/daromad koeffitsiyenti|Kapitalizatsiyaning daromadga nisbati LYRA (Lyra Therapeutics, Inc)|Kapitalizatsiyaning sotish hajmiga nisbati IBO|P/S multiplikatori TNFA (TNF Pharmaceuticals, Inc.)|YCBD (cbdMD Inc.) - Narxning sotuvga nisbati|PainReform - P/S multiplikatori|Narxning sotuvga nisbati CYTO|Lipella (LIPO) - Narxning daromadga nisbati|Narxning sotuvga nisbati OPTN (OptiNose Corp)|Narxning daromadga nisbati Pieris Pharmaceuticals|procapsgroup.com - Narxning sotuvga nisbati|P/S multiplikatori PTPI|QLI (Qilian International Holding Group) - Bozor kapitallashuvining daromadga nisbati|P/S multiplikatori SLRN (ACELYRIN, Inc.)